Newantifungal antibiotics, pradimicins A, B and C were isolated from the culture broth of actinomycete strains proposed as Actinomadura hibisca. They are orange to red pigments containing a benzo[a]naphthacenequinone chromophoresubstituted with a D-alanine, an aminosugarand a D-xylose (pradimicins A and C). 755 
In a systematic search for microbial metabolites effective against fungi and yeasts, actinomycete strains No. PI57-2 and Q278-4 isolated from soil samples collected in the Fiji Islands and India, respectively, were found to produce a complex of novel antibiotics designated pradimicin1~3). The producing strains were classified as an undescribed species of the genus Actinomaduraand namedActinomadura hibisca sp. nov. after taxonomical studies. The active principle was precipitated from the broth filtrate at pH 5.0 and purified by solvent partition and column chromatography to yield a major component pradimicin A and two minor components pradimicins B and C. Pradimicins A, B and C showed moderate in vitro activity against a wide variety of fungi and yeasts, some Gram-positive bacteria, and viruses. Most interestingly, they exhibited marked in vivo therapeutic activity against systemic fungal infections caused by Candida albicans, Aspergillusfumigatus and Cryptococcus neoformans strains in mice. Through chemical degradation and spectral analyses, the structures of pradimicins have been determined to be a benzo[tf]naphthacenequinone carrying D-alanine and sugars4~6). In this paper, we report the taxonomyof the producing strains and the production, isolation and physico-chemical properties of pradimicins. The biological activities of the antibiotics are reported in a companion paper7).
Taxonomyof the Producing Strain
The producing organisms, strain PI57-2 and strain Q278-4 were isolated from soil samples collected in the Fiji Islands and Andhra Pradesh State, India, respectively.
Morphological Characteristics
Both strains form white aerial myceliumand non-fragmentary substrate mycelium. Long straight spore-chains (10 to 50 spores per chain) are formed on all parts of the aerial mycelium. The spores are oblong in shape, 0.4 to 0.6 by 0.7 to 1.5jum in size, non-flagellate, and have smooth surface ( Fig. 1) . A fused coil of spore chain is occasionally formed intercalary or at the tip of long chains, which is observed by photomicroscopy as a small globose body (1.5 to 4jjm in diameter) ( Fig. 2 ). 1 Pradimicin A was originally called as BU-3608 A or BMY-28567, pradimicin B as BU-3608 B or BMY-28634 and pradimicin C as BU-3608 C or BMY-28747. 
Chemotaxonomical Studies
The whole-cell hydrolysate contains raeso-diaminopimelic acid, glucose and a small amount of madurose, hence the cell wall is type III and the whole cell-sugar is Pattern B. The phospholipids contain phosphatidylglycerol and phosphatidylinositol but lack nitrogenous phospholipids, hence belong to type P-I. The major menaquinone is MK-9(H6). Glycolate test is negative. Mycolate is absent.
Taxonomic Position Based on the major characteristics of strains PI57-2 and Q278-4, both strains were placed in the genus Actinomadura. Many strains of Actinomadura produce reddish pigments such as those identified as prodigiosins or anthracyclines, while these two strains produce three new red pigments, pradimicins A, B and C having benzo[tf]naphthaeenequinone as aglycone. The chemotaxonomy9) and numerical taxonomy10'1 1* of Actinomadura as well as the descriptions of manynew species of the genus such as Actinomadura atramentarial2) indicate that the two strains have some similarity to Actinomadura pelletieri. However, they are differentiated from A. pelletieri in the ability to form long spore-chains, the decomposition of adenine, the resistance to lysozyme, the hydrolysis of aesculin, the acid formation from cellobiose, and the production of pradimicins instead of prodigiosin of A. pelletieri (Table 2) . Thus, strains PI57-2 and Q278-4 are considered to be a new species ofActinomadura and are proposed to name Actinomadura hibisca sp. nov. Tomita (Origin: hi-bisika, L.n.; Gr hibiskos rose mallow, a plant with reddish flower reffering to the red diffusible pigments. The type strain is No. PI57-2 (ATCC 53557).
Antibiotic Production A slant culture ofA. hibisca strain P157-2 (ATCC 53557) or strain Q278-4 (ATCC 53646) was prepared using modified Bennett's agar medium consisting of soluble starch 0.5%, glucose 0.5%, fish meal extract 0.1%, yeast extract 0.1%, NZ-case (Sheffield). 0.2%, NaCl 0.2%, CaCO3 0.1% and agar 1.6%, and incubated at 28°C for 7 days. A portion of the microbial growth from the slant culture was transferred to a 500-ml Erlenmeyer flask containing 100ml of the seed medium consisting of glucose 1%, soluble starch 2%, NZ-amine A (Sheffield) 0.5%, yeast extract 0.5% and CaCO3 0.1%, adjusted to pH7.2 before sterilization.
The seed culture was incubated at 28°C for 4 days on a rotary shaker (200rpm); 5ml of the culture was transferred to a 500-ml Erlenmeyer flask which contained 100ml of fermentation medium consisting of glucose 3%, soybean meal 3%, Pharmamedia 0.5%, yeast extract 0.1% and CaCO30.3%. The fermentation was carried out at 28°C for 5 to 6 days on a rotary shaker.
Antibiotic production in the cultured broth was determined by the conventional broth dilution method using C. albicans A9540as the indicator organism in Sabouraud dextrose medium. The visible absorption at 500nm in 0.02n NaOH-MeOH (1 : 1) solution was used in parallel with the microbial assay. The Silica gel 60 (Merck, 5715), MeOAc-l-PrOH-28% NH4OH (45 : 105 : 60). Column: Microsorb Short One C18 (4.6mm i.d. x 100mm, Rainin Instrument), mobile phase: CH3CN-0.15% KH2PO4 adjusted to pH 3.5 with H3PO4 (7 : 17), flow rate: 1.2 ml/minute, detection: UV absorption at 254 nm. antibiotic potency reached a maximum of 650 fig/ml on the 5th day. The fermentation was also carried out in a 200-liter tank fermenter. Three liters of the seed culture were used to inoculate 120 liters of production medium consisting of glucose 3%, Protein S (Ajinomoto Co.) 3% and CaCO3 0.3%. The tank fermenter was operated at 28°C with agitation at 250rpmand an aeration rate of 120 liters/minute. The pH of the cultured broth gradually rose with the progress of fermentation and reached 7.9 after 96 hours. The antibiotic potency was 820^g/ml.
Strain PI57-2 produced pradimicin A as a major component and a small amount of pradimicins B and C in the broth; strain Q278-4 produced pradimicins A and C as major components with a small amount of pradimicin B.
The pradimicin components in the broth were analyzed by HPLC.The HPLCmobility of each component is shown in Table 3 . An example of production ratio of pradimicins A, B and C in the tank fermentation using strains PI57-2 and Q278-4 is shown in Table 4 . Isolation and Purification The isolation procedure for the pradimicin components is summarized in Fig. 4 and the details are described in the previous paper5). Crystallization of the purified pradimicin A-HC1 from MeOAc-1-PrOH-O.l N NaOHgave fine needles of the monosodiumsalt of the antibiotic. Whenthe salt was dissolved in water and adjusted to pH 5.0 by 0.1 n HC1, a precipitate of the zwitterionic form of pradimicin A deposited. Aqueous solution of pradimicin B-HC1 and pradimicin C HC1 were similarly treated with 0.1n NaOHto obtain the 
Physico-chemical Properties
Zwitterionic pradimicins A, B and C exhibited the physico-chemical properties as summarized in Table 3 . They are soluble in A^,A^-dimethylformamide, dimethyl sulfoxide and acidic and alkaline water, slightly soluble in water, methanol, ethanol and 1-butanol but insoluble in commonorganic solvents. The UVand visible spectrum and IR spectrum of pradimicin A are shown in Figs. 5 and 6, respectively. The CD spectrum ofpradimicin A (Ae°xt°r^eHC1nm (As) 213 (+ 1.9), 244 (-17.7), 289 (+ 15.3), 335 (-6.1), 515 (+ 6.6)) corresponded well with that of its aglycone reported before4)5). Fig. 7 shows the XHNMRspectrum of pradimicin A. As has been reported in a separate paper4'5), the structures of pradimicins A, B and C were determined to have a benzo[a]naphthacenequinone nucleus substituted with D-alanine and sugars ( Fig.8 ).
Discussion
Novel antifungal antibiotics pradimicins A, B and C were discovered as the metabolites of a new species of the genus Actinomadura, later named Actinomadura hibisca sp. nov. Pradimicins A, B and C are red amorphous powders having characteristic UVabsorption. The structural studies have revealed that they share the same unique aglycone, a dihydro benzo[>]naphthacenequinone nucleus substituted with D-alanine, and differ from each other in the type and number of sugar substituents (Fig. 8 ). As discussed in the following paper, pradimicins A, B and C demonstrated moderate in vitro activity against various clinically important fungi and yeasts and impressive in vivo activity against those fungal infections. Recently, a complex of closely related antibiotics, benanomicin, was reported13~15). Benanomicin B is considered to be identical with pradimicin C from the reported data.
